Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed 38 (TEX38) is a protein expressed predominantly in the testis of humans, and primarily localizes to testicular tissue including germ cells[3][4]. It is a protein of unknown detailed function, but mouse studies suggest possible roles in cell differentiation and metabolic processes involving carbohydrate derivatives[6]. Diseases associated with mutations or alterations in TEX38 include male infertility, and it has been listed as associated with Phosphoglycerate Kinase 1 deficiency; however, its specific mechanistic involvement in disease is not well characterized[3]. TEX38 is not recognized as a therapeutic receptor, enzyme, or common drug target, and no drugs are known to interact with it. Its expression is highly testis-specific, supporting a role in spermatogenesis or testicular development[2][4]. No aliases are currently in active use besides older gene symbols, and no evidence indicates incorrectness or misannotation[3][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed 38 (TEX38).